What is SYRE's dilution risk score?

SYRE has a latest available DilutionScore record of 53/100, categorized as high dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for SYRE, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for SYRE?

DilutionWatch tracks 25 SEC filing types for SYRE including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect SYRE shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For SYRE, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for SYRE tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for SYRE. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

SYRE Dilution Risk Score: 53/100 (HIGH)

Score Breakdown

📋 Offering Ability

80

💰 Cash Runway

40

📊 Float Risk

10

⚠️ Warrant Exposure

15

🔄 Convertible Debt

15

Dilution Forecast

⛅

Watch

Minor dilution signals detected

model est. 19%

💰 Capital Raise model 38%

• Active shelf registration ($500M, 8% of market cap)

• Active ATM program with $403M remaining capacity

🔔 Track SYRE — Get forecast alerts →

Market Data

Market Cap$6.38B

Shares Outstanding88.17M

Float80.93M

Cash$200.08M

DebtN/A

Short InterestN/A

Institutional Holdings

QoQ: ↑ 17.0% shares (2026Q1 vs prior)

199 institutional holders · 95.93M shares

#1 FMR LLC 11.78M shares

#2 PERCEPTIVE ADVISORS LLC 7.57M shares

#3 VANGUARD CAPITAL MANAGEMENT LLC 6.11M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest12.14M

Days to Cover13.5

% of Float15.0%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2024-12-31

8-K 8K EVENT 2026-04-16

424B5 ATM 2026-04-16

424B5 ATM 2026-04-13

4 INSIDER TRANSACTION 2026-04-03

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual SYRE Dilution Snapshot

Spyre Therapeutics, Inc. (SYRE) has a DilutionScore of 53/100, rated High dilution risk. Score date: August 28, 2026.

Stored shelf registration capacity: $500.0M.
Stored ATM program remaining capacity: $403.0M.
Recent SEC activity tracked for SYRE: 8-K on 2026-04-16; 424B5 on 2026-04-16; 424B5 on 2026-04-13.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.